01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 27.02
−9.27%Leverage
- Debt / equity
- 0.38x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.24x
- Debt / EBITDA
- 30.83x
- Net debt / EBITDA
- 7.31x
Liquidity & coverage
- Current ratio
- 3.77x
- Quick ratio
- 3.58x
- Cash ratio
- 2.54x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- HKD 2.6B
Cash & dividend
- FCF / debt
- -0.14x
- Cash flow / debt
- -0.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026